SCHEMBL2104

SCHEMBL2104

CCOC(=O)CCN(C)c1ccc(-c2ccccc2C#N)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 1/20 0.43
ESR2 Q92731 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 2/20 0.42
FFAR1 O14842 1/20 0.42
AKR1B1 P15121 1/20 0.42
KDM4E B2RXH2 1/20 0.42
GRIA2 P42262 1/20 0.40
GRIA4 P48058 1/20 0.40
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 1/20 0.40
SQOR Q9Y6N5 1/20 0.39
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
PTPN5 P54829 1/20 0.38
LTA4H P09960 2/20 0.38
MME P08473 1/20 0.38
OXTR P30559 2/20 0.37
AVPR1A P37288 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2730 0.80 LTB4R2 (0.53) OXTRAVPR1ALTB4R2
SCHEMBL2604 0.80 NLRP3 (0.41) NLRP3ESR2ALDH1A1FFAR1AKR1B1
SCHEMBL2686 0.79 ESR2 (0.40) NLRP3ESR2ALDH1A1FFAR1AKR1B1
SCHEMBL2405898 0.78 SMN1; SMN2 (0.65) SMN1; SMN2ALDH1A1MAPTCYP4F2CYP4A11
SCHEMBL1628 0.77 ESR2 (0.43) ESR2SMN1; SMN2ALDH1A1FFAR1AKR1B1
SCHEMBL2103 0.76 MYC (0.47) NLRP3ESR2SMN1; SMN2ALDH1A1FFAR1
SCHEMBL2934 0.75 GPR119 (0.43) ESR2SMN1; SMN2ALDH1A1KDM4EGRIA2
SCHEMBL7270546 0.75 ESR2 (0.46) ESR2SMN1; SMN2ALDH1A1FFAR1AKR1B1
SCHEMBL3058 0.73 OXTR (0.41) ESR2SMN1; SMN2ALDH1A1FFAR1AKR1B1
SCHEMBL6555905 0.73 SMN1; SMN2 (0.47) SMN1; SMN2GAAL3MBTL1MAPTCYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965592-A HYPOTENSIVE AGENTS NOVARTIS CORPORATION (US) 1999-10-12 US disclosed
EP-0443983-B1 Acyl compounds CIBA GEIGY AG (CH) 1996-02-28 EP disclosed
US-5399578-A Hypotensive; valsartan; high blood pressure and cardiac insufficiency CIBA-GEIGY CORP (US) 1995-03-21 US disclosed
EP-0443983-A1 Acyl compounds CIBA-GEIGY AG (CH) 1991-08-28 EP disclosed